Drug repositioning and its aspects in clinical diabetology

被引:0
|
作者
Pokoly, Bence [1 ,2 ]
Somogyi, Aniko [3 ]
机构
[1] Orszag Reumatol Fizioterap Int, Orszag Mozgasszerv Int, Budapest, Hungary
[2] Szent Margit Korhaz, Budapest, Hungary
[3] Semmelweis Egyet, Altalan Orvostudomany Kar, Belgyogyaszat Hematol Klinika, Budapest, Hungary
关键词
drug repositioning; diabetes mellitus; treatment; CARDIOVASCULAR OUTCOMES; THALIDOMIDE; LIRAGLUTIDE;
D O I
10.1556/650.2024.33177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug repositioning is a special and increasingly utilized way of drug development. As a result of the procedure, drugs and active ingredients that are already on the market for the treatment of certain diseases or are in various phases of development are being successfully used with new indications, some of which are sometimes completely different from the original ones. In the first half of our review, we give a brief overview of this process, outline its various advantages and potential pitfalls. After the general introductory part, we will examine the more successful areas of application of the drugs that were previously marketed as antidiabetics, and then we will mention some preparations that can now also be used in the treatment of diabetes mellitus, due to their significant blood sugar lowering properties that have been recognized in the meantime. Orv Hetil. 2024; 165(49): 1919-1926.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [1] Centrality analysis in a drug network and its application to drug repositioning
    Keng, Ying Ying
    Kwa, Kiam Heong
    Ratnavelu, Kurunathan
    APPLIED MATHEMATICS AND COMPUTATION, 2021, 395
  • [3] Some Aspects and Convergence of Human and Veterinary Drug Repositioning
    Mag, Patrik
    Nemes-Terenyi, Melinda
    Jerzsele, Akos
    Matyus, Peter
    MOLECULES, 2024, 29 (18):
  • [4] Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
    Zhu, Sha
    Bai, Qifeng
    Li, Lanqing
    Xu, Tingyang
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 2839 - 2847
  • [5] Current status of drug repositioning in hematology
    Ohmoto, Akihiro
    Fuji, Shigeo
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (11) : 1005 - 1011
  • [6] Recycling side-effects into clinical markers for drug repositioning
    Duran-Frigola, Miquel
    Aloy, Patrick
    GENOME MEDICINE, 2012, 4
  • [7] Recycling side-effects into clinical markers for drug repositioning
    Miquel Duran-Frigola
    Patrick Aloy
    Genome Medicine, 4
  • [8] Clinical trials on drug repositioning for COVID-19 treatment
    Viveiros Rosa, Sandro G.
    Santos, Wilson C.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2020, 44
  • [9] Drug Repositioning An Approach for Drug Discovery
    Vora, Parin K.
    Somani, Rakesh R.
    Jain, Madhuri H.
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2016, 13 (05) : 363 - 376
  • [10] Drug repositioning: A bibliometric analysis
    Sun, Guojun
    Dong, Dashun
    Dong, Zuojun
    Zhang, Qian
    Fang, Hui
    Wang, Chaojun
    Zhang, Shaoya
    Wu, Shuaijun
    Dong, Yichen
    Wan, Yuehua
    FRONTIERS IN PHARMACOLOGY, 2022, 13